Christoph is also the
Managing Director of hameln pharmaceuticals gmbh based in Hameln
in Germany. hameln pharmaceuticals is a family business established
by Dr.Gunther Kerstein in 1950: it is engaged in the manufacture
and supply of generic injectable drugs. hameln has an extensive
portfolio of injectable medicines which are marketed in many countries.
Christoph studied pharmacy at Aston University in Birmingham and
became a MRPharmS in 1987.
Stephen Watkin
- Managing Director
Stephen Watkin joined
hameln pharmaceuticals ltd as Managing Director at the beginning
of 2003. He is charged with increasing customer focus of the firm
as well as maintaining hameln pharmaceuticals ltd reputation for
providing a professional and reliable service. Stephen will also
be working to expand the hameln pharmaceuticals ltd product range
of sterile generic injections and to introduce new customers to
hameln pharmaceuticals ltd products. Stephen has a degree in Pharmacology
and Chemistry from Sheffield University and has held a number of
management, sales and marketing positions in the pharmaceutical
industry. Before joining hameln pharmaceuticals ltd he was Managing
Director of Abbott Laboratories in Romania.
Mike Coleman - General Manager
Mike is hameln pharmaceuticals ltd
General Manager and manages the contracts with supplies divisions
and hospitals. Mike’s considerable experience in the market
is invaluable to ensure that hameln pharmaceuticals ltd products
arrive at the right time in perfect condition whilst meeting the
customers’ needs.
